好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Tacrolimus Neurotoxicity Masked by Daily Cannabis Use
Epilepsy/Clinical Neurophysiology (EEG)
P7 - Poster Session 7 (5:30 PM-6:30 PM)
12-006
N/A
Tacrolimus is a calcineurin inhibitor that is commonly used in renal transplantation. Given its narrow therapeutic window, drug interactions and established neurotoxicity, careful consideration of its effects on patients with neurologic concerns is necessary. We present a case of partial status epilepticus in a patient on chronic tacrolimus who had subsequent encephalopathy persistent throughout hospitalization that improved when tacrolimus was discontinued.
N/A

A 67-year-old man with a history of daily cannabis use and renal transplant on tacrolimus with no prior seizures presented to an outside hospital with shoulder pain. Soon after receiving morphine sulfate injection in the emergency department, he became unresponsive and had right-sided limb jerking with right sided eye deviation. Electroencephalogram (EEG) revealed focal status epilepticus originating from the left temporal region. He was intubated and transferred for higher level of care.

During hospitalization, the patient remained encephalopathic and underwent workup including computed tomography of the head, magnetic resonance imaging of the brain, cerebrospinal fluid analysis and serum studies, which were negative for any pathology for seizure. Tacrolimus dose was increased due to competing phenytoin administration and the patient subsequently had another seizure. Tacrolimus was switched to cyclosporine and the patient began to show improvement clinically and on EEG. However, due to sub-therapeutic cyclosporine levels, he was switched back to tacrolimus and had another seizure. As a result, tacrolimus was discontinued again and the patient remained seizure free with continued improvement in mentation until his 3 month follow up.

This case highlights the neurotoxic potential of tacrolimus in patients with no prior seizures when administrating pro-convulsant agents such as morphine. Of note, abrupt discontinuation of cannabis during hospitalization probably unveiled the tacrolimus neurotoxicity.

Authors/Disclosures

PRESENTER
No disclosure on file
William Ueng, MD (UCSD Medical Center) Dr. Ueng has nothing to disclose.
Shweta Varade, MD Dr. Varade has nothing to disclose.
Preet M. Varade, MD (Lehigh Valley Hospital - Cedar Crest) Dr. Varade has nothing to disclose.